PET scan for metastatic lung cancer
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a new type of PET scan that may help doctors see small cell lung cancer more clearly. It could improve treatment planning by showing where cancer has spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have small cell lung cancer that has spread and cannot be removed by surgery.
- You have not yet received any treatment for this cancer.
- You are 18 years or older.
- You are willing to have a PET scan and a small tissue sample taken.
- You are generally healthy enough for this imaging test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET scan tracer called [68Ga]Ga-PentixaFor to see if it can better detect breast cancer that has spread. You may benefit if you have triple negative breast cancer that has come back or spread, and you are looking for more precise imaging.
This study uses a special PET scan (68Ga-PFD3) to take pictures of small cell lung cancer tumors. The goal is to see if this scan can help doctors better diagnose and evaluate the cancer, which may guide treatment decisions.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This study uses a special PET imaging scan to help doctors see how well pembrolizumab (an immunotherapy drug) is working against advanced non-small cell lung cancer. You'll receive the scan along with your regular pembrolizumab treatment and possible radiation therapy to help measure treatment response.
This trial tests a special PET scan (68Ga-grazytracer) to see if it can predict early whether immunotherapy is working in people with lung cancer that can be surgically removed. If successful, this scan could help doctors tailor treatment sooner.
Hear when a new Small Cell Lung Carcinoma (SCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.